Knockdown of SPON2 inhibits the growth of triple-negative breast cancer
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1141417
Abstract: Objective Spondin-2 (SPON2) is highly expressed in a variety of tumors and has been associated with poor prognosis, but the relationship to triple-negative breast cancer (TNBC) is unclear. The aim of this study is to… read more here.
Keywords: cancer; breast; expression; knockdown spon2 ... See more keywords